-
G648434-50mg
GZD856 formic (C007B-357456)
Price: $2,572.48List Price: $2,858.31GZD856 formic is a potent and orally active PDGFRα/β inhibitor, with IC 50 s of 68.6 and 136.6 nM, respectively. GZD856 formic is also a Bcr-Abl T315I inhibitor, with IC 50 s of 19.9 and 15.4 nM for native Bcr-Abl and the T315I mutant. GZD856 formic -
G648434-5mg
GZD856 formic (C007B-357457)
Price: $518.18List Price: $575.75GZD856 formic is a potent and orally active PDGFRα/β inhibitor, with IC 50 s of 68.6 and 136.6 nM, respectively. GZD856 formic is also a Bcr-Abl T315I inhibitor, with IC 50 s of 19.9 and 15.4 nM for native Bcr-Abl and the T315I mutant. GZD856 formic -
ITA2915-100u
Immunotag™ CREB3L1,OASIS Antibody* (C009B-082133)
Price: $567.91List Price: $631.01Immunotag™ CREB3L1,OASIS Antibody* -
ITA2915-200u
Immunotag™ CREB3L1,OASIS Antibody* (C009B-082143)
Price: $708.48List Price: $787.20Immunotag™ CREB3L1,OASIS Antibody* -
I646172-100mg
Imrecoxib (C007B-361826)
Price: $117.52List Price: $130.58Imrecoxib (BAP-909) is a novel and selective cyclooxygenase 2 ( COX-2 ) inhibitor with an IC 50 value of 18 nM, it also inhibits COX1- activity with an IC 50 value of 115 nM. Imrecoxib (BAP-909) has anti-inflammatory effectIn VitroImrecoxib -
I646172-50mg
Imrecoxib (C007B-361827)
Price: $83.80List Price: $93.11Imrecoxib (BAP-909) is a novel and selective cyclooxygenase 2 ( COX-2 ) inhibitor with an IC 50 value of 18 nM, it also inhibits COX1- activity with an IC 50 value of 115 nM. Imrecoxib (BAP-909) has anti-inflammatory effectIn VitroImrecoxib -
I654473-1ml
Imrecoxib (C007B-362523)
Price: $93.80List Price: $104.22Imrecoxib (BAP-909) is a novel and selective cyclooxygenase 2 ( COX-2 ) inhibitor with an IC 50 value of 18 nM, it also inhibits COX1- activity with an IC 50 value of 115 nM. Imrecoxib (BAP-909) has anti-inflammatory effectIn VitroImrecoxib -
Ab170867-100μg
Inebilizumab (anti-CD19) (C007B-327692)
Price: $99.80List Price: $110.89Inebilizumab (anti-CD19) is an anti-CD19 monoclonal antibody (mAb) with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab (anti-CD19) can be used for multiple sclerosis and neuromyelitis optica -
Ab170867-10mg
Inebilizumab (anti-CD19) (C007B-327693)
Price: $1,155.28List Price: $1,283.65Inebilizumab (anti-CD19) is an anti-CD19 monoclonal antibody (mAb) with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab (anti-CD19) can be used for multiple sclerosis and neuromyelitis optica -
Ab170867-1mg
Inebilizumab (anti-CD19) (C007B-327694)
Price: $350.69List Price: $389.66Inebilizumab (anti-CD19) is an anti-CD19 monoclonal antibody (mAb) with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab (anti-CD19) can be used for multiple sclerosis and neuromyelitis optica -
Ab170867-5mg
Inebilizumab (anti-CD19) (C007B-327695)
Price: $717.45List Price: $797.16Inebilizumab (anti-CD19) is an anti-CD19 monoclonal antibody (mAb) with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab (anti-CD19) can be used for multiple sclerosis and neuromyelitis optica -
5060690001
INSOLUTION EZH2 INHIBITOR DZNEP
Price: $318.80List Price: $354.22A cell-permeable compound that is shown (at 1 µM concentrations) to inhibit EZH2-mediated trimethylation of K27 on histone H3 and induces the expression of cell-cycle regulatory genes, p21 and p27, as well as the cell death regulator, FBXO32,